Evidence map›Paper›PMID 41155923›Full record

ArticlePharmaceutics2025

Nanoparticles Loaded with

Nancy Nallely Espinosa-Carranza, Rocío Álvarez-Román, David A Silva-Mares, Luis A Pérez-López, Catalina Leos-Rivas, Catalina Rivas-Morales, Juan Gabriel Báez-González, Sergio Arturo Galindo-Rodríguez

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nancy Nallely Espinosa-CarranzaLaboratorio de Nanotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico.
Rocío Álvarez-RománDepartamento de Química Analítica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey 64460, Nuevo León, Mexico.ORCID 0000-0002-7459-4150
David A Silva-MaresDepartamento de Química Analítica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey 64460, Nuevo León, Mexico.ORCID 0000-0002-8177-3595
Luis A Pérez-LópezDepartamento de Química Analítica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey 64460, Nuevo León, Mexico.
Catalina Leos-RivasLaboratorio de Nanotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico.
Catalina Rivas-MoralesLaboratorio de Nanotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico.
Juan Gabriel Báez-GonzálezDepartamento de Alimentos, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico.ORCID 0000-0003-0509-4678
Sergio Arturo Galindo-RodríguezLaboratorio de Nanotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico.ORCID 0000-0002-5734-7246

Funding

Universidad Autónoma de Nuevo León ProACTI 40-BQ-2023 and 66-ByQ-2024
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiviralessential oilsHVS-1Lippia graveolensnanoparticles

Identifiers

PMID41155923
PMCPMC12566687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.